The SARS-CoV-2 spike S1 protein induces global proteomic changes in ATII-like rat L2 cells that are attenuated by hyaluronan
- 1 April 2023
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 324 (4) , L413-L432
Abstract
The COVID-19 pandemic continues to impose a major impact on global health and economy since its identification in early 2020, causing significant morbidity and mortality worldwide. Caused by the SARS-CoV-2 virus, along with a growing number of variants, COVID-19 has led to 651,918,402 confirmed cases and 6,656,601 deaths worldwide (as of December 27, 2022; https://covid19.who.int/ ). Despite advances in our understanding of COVID-19 pathogenesis, the precise mechanism by which SARS-CoV2 causes epithelial injury is incompletely understood. In this current study, robust application of global-discovery proteomics identified highly significant induced changes by the Spike S1 protein of SARS-CoV-2 in the proteome of alveolar type II (ATII)-like rat L2 cells that lack ACE2 receptors. Systems biology analysis revealed that the S1-induced proteomics changes were associated with three significant network hubs: E2F1, CREB1/RelA, and ROCK2/RhoA. We also found that pretreatment of L2 cells with high molecular weight hyaluronan (HMW-HA) greatly attenuated the S1 effects on the proteome. Western blotting analysis and cell cycle measurements confirmed the S1 upregulation of E2F1 and ROCK2/RhoA in L2 cells and the protective effects of HMW-HA. Taken as a whole, our studies revealed profound and novel biological changes that contribute to our current understanding of both S1 and hyaluronan biology. These data show that the S1 protein may contribute to epithelial injury induced by SARS-CoV-2. In addition, our work supports the potential benefit of HMW-HA in ameliorating SARS CoV-2-induced cell injury.Keywords
All Related Versions
Funding Information
- HHS | NIH | National Institute of Environmental Health Sciences (ES103342)
- HHS | NIH | National Cancer Institute (P30CA013148)
- HHS | NIH | National Institute of Environmental Health Sciences (3UO1ES026458 03S1)
- HHS | NIH | National Institute of Environmental Health Sciences (5UO1ES026458)
- HHS | NIH | National Institute of Environmental Health Sciences (1R21ES032956)
- HHS | NIH | National Institute of Environmental Health Sciences (ES102605)
- University of Alabama at Birmingham (REINVENT grant from the Department of Anesthesiology and Perioperative Medicine)
This publication has 84 references indexed in Scilit:
- Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44Journal of Experimental Medicine, 2011
- Hyaluronan as an Immune Regulator in Human DiseasesPhysiological Reviews, 2011
- The Role of the Transcription Factor CREB in Immune FunctionThe Journal of Immunology, 2010
- Regulation of Non‐Infectious Lung Injury, Inflammation, and Repair by the Extracellular Matrix Glycosaminoglycan HyaluronanThe Anatomical Record, 2010
- TLR4 Is Necessary for Hyaluronan-mediated Airway Hyperresponsiveness after Ozone InhalationAmerican Journal of Respiratory and Critical Care Medicine, 2010
- The lectin-like domain of TNF protects from listeriolysin-induced hyperpermeability in human pulmonary microvascular endothelial cells — A crucial role for protein kinase C-α inhibitionVascular Pharmacology, 2010
- Software Tool for Researching Annotations of Proteins: Open-Source Protein Annotation Software with Data VisualizationAnalytical Chemistry, 2009
- Hyaluronan Mediates Ozone-induced Airway Hyperresponsiveness in MiceJournal of Biological Chemistry, 2009
- High-molecular-weight hyaluronan – a possible new treatment for sepsis-induced lung injury: a preclinical study in mechanically ventilated ratsCritical Care, 2008
- Empirical Statistical Model To Estimate the Accuracy of Peptide Identifications Made by MS/MS and Database SearchAnalytical Chemistry, 2002